244 related articles for article (PubMed ID: 24492224)
1. [Anti-counterfeit activities of pharmaceutical companies in Japan: for patient safety].
Shofuda K; Aragane K; Igari Y; Matsumoto K; Ito K
Yakugaku Zasshi; 2014; 134(2):203-11. PubMed ID: 24492224
[TBL] [Abstract][Full Text] [Related]
2. [Counterfeit medicines--Japan and the world].
Sato D
Yakugaku Zasshi; 2014; 134(2):213-22. PubMed ID: 24492225
[TBL] [Abstract][Full Text] [Related]
3. Fighting trafficking of falsified and substandard medicinal products in Russia.
Fayzrakhmanov NF
Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
[TBL] [Abstract][Full Text] [Related]
4. [Counterfeit drugs as a gobal threat to health].
Golocorbin Kon S; Mikov M
Med Pregl; 2011; 64(5-6):285-90. PubMed ID: 21789919
[TBL] [Abstract][Full Text] [Related]
5. Understanding and fighting the medicine counterfeit market.
Dégardin K; Roggo Y; Margot P
J Pharm Biomed Anal; 2014 Jan; 87():167-75. PubMed ID: 23384475
[TBL] [Abstract][Full Text] [Related]
6. The Challenge of Counterfeit Drugs: A Comprehensive Review on Prevalence, Detection and Preventive Measures.
Kumar B; Baldi A
Curr Drug Saf; 2016; 11(2):112-20. PubMed ID: 26463250
[TBL] [Abstract][Full Text] [Related]
7. [Operation Pangea - standing together in combat against international pharmaceutical crime].
Smolka K; Gronwald K
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1233-1239. PubMed ID: 28929174
[TBL] [Abstract][Full Text] [Related]
8. [Counterfeit Medicines in Internet and the Fakeshare European Project: Experiences and Activities in Spain].
Catalán-Matamoros D; González-Ochando N; Pecharroman-Arribas H; Fernández-Muelas A; Bentolila-Benchimol SS; IbarraLorente M
Rev Esp Salud Publica; 2016 Aug; 90():e1-e14. PubMed ID: 27529446
[TBL] [Abstract][Full Text] [Related]
9. [Counterfeit and contraband drugs in Brazil: overview and prospects for preventing their use].
Hurtado RL; Lasmar MC
Cad Saude Publica; 2014 Apr; 30(4):891-5. PubMed ID: 24896066
[TBL] [Abstract][Full Text] [Related]
10. Economic analysis of use of counterfeit drugs: health impairment risk of counterfeit phosphodiesterase type 5 inhibitor taken as an example.
Sugita M; Miyakawa M
Environ Health Prev Med; 2010 Jul; 15(4):244-51. PubMed ID: 21432552
[TBL] [Abstract][Full Text] [Related]
11. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
Theriaca; 2016; (43):9-61. PubMed ID: 27491172
[TBL] [Abstract][Full Text] [Related]
12. [The role of German official medicines control laboratories in combating counterfeit medicines].
Wiegard A; Heuermann M
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1214-1220. PubMed ID: 28948293
[TBL] [Abstract][Full Text] [Related]
13. Combating counterfeit medicines and illicit trade in tobacco products: minefields in global health governance.
Liberman J
J Law Med Ethics; 2012; 40(2):326-47. PubMed ID: 22789049
[TBL] [Abstract][Full Text] [Related]
14. Internet-ordered viagra (sildenafil citrate) is rarely genuine.
Campbell N; Clark JP; Stecher VJ; Goldstein I
J Sex Med; 2012 Nov; 9(11):2943-51. PubMed ID: 22925379
[TBL] [Abstract][Full Text] [Related]
15. The global counterfeit drug trade: patient safety and public health risks.
Mackey TK; Liang BA
J Pharm Sci; 2011 Nov; 100(11):4571-9. PubMed ID: 21698604
[TBL] [Abstract][Full Text] [Related]
16. [Current cases of falsified medicinal products within the competence of the Federal Institute for Drugs and Medical Devices (BfArM) : Case studies and extent].
Wittstock M; Paeschke N
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1196-1202. PubMed ID: 28980029
[TBL] [Abstract][Full Text] [Related]
17. [Front line of combating counterfeit medicines, globally and locally].
Kimura K
Yakugaku Zasshi; 2014; 134(2):195-6. PubMed ID: 24492222
[No Abstract] [Full Text] [Related]
18. Counterfeit phosphodiesterase type 5 inhibitors pose significant safety risks.
Jackson G; Arver S; Banks I; Stecher VJ
Int J Clin Pract; 2010 Mar; 64(4):497-504. PubMed ID: 20088883
[TBL] [Abstract][Full Text] [Related]
19. [Impact of European e-commerce liberalisation on pharmaceutical crime : The ALPhA research project].
Sinn A
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1245-1254. PubMed ID: 28929171
[TBL] [Abstract][Full Text] [Related]
20. A survey on illegal and counterfeit medicines for the treatment of erectile dysfunctions in Italy.
Gaudiano MC; Manna L; Rodomonte AL; Bartolomei M; Bertocchi P; Gallinella B; Antoniella E; Muleri N; Civitelli G; Alimonti S; Romanini L; Rufini L; Valvo L
J Sex Med; 2012 Aug; 9(8):2130-7. PubMed ID: 22612848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
